| Biological Information | |
|---|---|
| Background Information: | TWEAK is a member of the tumor necrosis factor (TNF) superfamily and promotes apoptosis in a cell-type specific manner via interaction with its receptor, TWEAKR. It also modulates endothelial cell growth and migration. TWEAK is produced by leukocytes, and exists as both a transmembrane and a secreted soluble form. Provided as 25 μg of dry powder alongside reconstitution buffer. |
| Target Name: | TWEAK |
| Usage | |
| Product Type: | Recombinant Proteins |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at -20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Recombinant Human TWEAK
Recombinant Human TWEAK is an agonist for TWEAKR. This product is provided as 25 μg of dry powder alongside reconstitution buffer.
Datasheets
92-1297 Datasheet
View Document